微生物游离DNA可识别感染性心内膜炎的致病病原体,且在既往接受抗生素治疗的患者中可检测时间比常规血培养更长
本研究对30例疑似感染性心内膜炎患者连续采集血样,提取血浆微生物游离DNA(mcfDNA)行二代测序,仅23例确诊IE纳入分析。mcfDNA与血培养敏感性均为87%;自抗生素治疗开始,mcfDNA阳性持续时间中位约38.1天,血培养为3.7天(比例优势比2.952,P=0.02771)。外科感染源控制后mcfDNA(log10)水平显著下降(-0.3 MPM log10单位,95%可信区间-0.45至-0.14)。
要点
- 确诊IE患者中mcfDNA与血培养敏感性均为87%。
- 自抗生素治疗开始,mcfDNA阳性持续中位约38.1天,血培养3.7天。
- 外科感染源控制后mcfDNA(log10)水平显著下降。
核心结论
- mcfDNA可准确识别感染性心内膜炎的微生物病因。
- 连续mcfDNA水平可能最终有助于通过估计患者感染负荷和治疗反应来个体化治疗。
研究设计与样本
- 研究连续采集疑似感染性心内膜炎患者的血样,从血浆提取mcfDNA行二代测序,读段比对含>1400种病原体DNA序列的文库。
- 高于统计阈值的病原体mcfDNA以每毫升分子数(MPM)报告并定量,每2-3天采集一次,共7次或至出院。
- 30例疑似IE患者中23例确诊IE、2例可能IE、5例按改良Duke标准排除IE,仅23例确诊IE纳入分析。
主要发现
- 确诊IE患者中mcfDNA与血培养敏感性均为87%。
- 自抗生素治疗开始,mcfDNA阳性持续时间中位估计约38.1天,血培养为3.7天(比例优势比2.952;P=0.02771),采用半参数生存分析。
- 外科感染源控制后mcfDNA(log10)水平显著下降(-0.3 MPM log10单位,95%可信区间-0.45至-0.14;术前与术后比较,后验概率>0.99)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnosis of infective endocarditis (IE) can be difficult, particularly if blood cultures fail to yield a pathogen. This study evaluates the potential utility of microbial cell-free DNA (mcfDNA) as a tool to identify the microbial etiology of IE. METHODS: Blood samples from patients with suspected IE were serially collected. mcfDNA was extracted from plasma and underwent next-generation sequencing. Reads were aligned against a library containing DNA sequences belonging to >1400 different pathogens. mcfDNA from organisms present above a statistical threshold were reported and quantified in molecules per milliliter (MPM). Additional mcfDNA was collected on each subject every 2-3 days for a total of 7 collections or until discharge. RESULTS: Of 30 enrolled patients with suspected IE, 23 had definite IE, 2 had possible IE, and IE was rejected in 5 patients by modified Duke Criteria. Only the 23 patients with definite IE were included for analysis. Both mcfDNA and blood cultures achieved a sensitivity of 87%. The median duration of positivity from antibiotic treatment initiation was estimated to be approximately 38.1 days for mcfDNA versus 3.7 days for blood culture (proportional odds, 2.952; P = .02771), using a semiparametric survival analysis. mcfDNA (log10) levels significantly declined (-0.3 MPM log10 units, 95% credible interval -0.45 to -0.14) after surgical source control was performed (pre- vs postprocedure, posterior probability >0.99). CONCLUSION: mcfDNA accurately identifies the microbial etiology of IE. Sequential mcfDNA levels may ultimately help to individualize therapy by estimating a patient's burden of infection and response to treatment.
引用
- Eichenberger EM, Degner N, Scott ER, et al. Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic Therapy. Clin Infect Dis. 2023. PMID: 35684984. doi:10.1093/cid/ciac426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。